<unk> , sold under the brand name Nurtec ODT, is a medication for the acute treatment of migraine with or without aura in adults and preventative treatment of episodic migraine in adults. Taken by mouth to dissolve on or under the tongue,<unk>  takes effect within an hour and can provide relief from migraine headache for up to 48 hours. It works by blocking CGRP receptors. In the United States,<unk>  was approved for treating acute migraine in February 2020 and its approval was extended to preventing episodic migraine in June 2021. It is produced and marketed by Biohaven Pharmaceuticals, based in New Haven, Connecticut. During March 2021, Nurtec ODT obtained approval from the United Arab emirates and Israel.
Rimegepant
Suvorexant
Ubrogepant
Icatibant
Fosaprepitant
Burapitant
Veristrat
Almorexant